Latest News and Press Releases
Want to stay updated on the latest news?
-
26. september, 2025Meddelelse BioPorto sponsorerer konferencer om pædiatrisk intensiv behandling med præsentation af nye videnskabelige data om NGAL KØBENHAVN, DANMARK og BOSTON, MA, USA, 26....
-
September 26, 2025News Release BioPorto Sponsors Conferences on Pediatric Critical Care with New NGAL Scientific Data Presented COPENHAGEN, DENMARK and BOSTON, MA, USA, September 26 – BioPorto A/S...
-
11. september, 2025Meddelelse US News & World Report-webinaret “New Frontiers in Kidney Care” fremhæver NGAL-biomarkøren KØBENHAVN, DANMARK og BOSTON, MA, USA, 11. september – BioPorto A/S...
-
September 11, 2025News Release US News & World Report Webinar “New Frontiers in Kidney Care” features NGAL biomarker COPENHAGEN, DENMARK and BOSTON, MA, USA, September 11 – BioPorto A/S...
-
1. september 2025 Meddelelse nr. 20 Tildeling af Warrants København, Danmark, den 1. september 2025 (GLOBE NEWSWIRE) –...
-
September 1, 2025 Announcement no. 20 Grant of Warrants Copenhagen, Denmark, September 1, 2025, (GLOBE NEWSWIRE) – The...
-
28. august 2025Meddelelse ProNephro AKI™ (NGAL), til tidlig diagnosticering af akut nyreskade, er nu kommercielt tilgængelig på laboratorier i USA gennem BioPortos samarbejde med Roche Diagnostics. ...
-
August 28, 2025News Release ProNephro AKI™ (NGAL), early detection test for Acute Kidney Injury, now commercially available to US Labs through BioPorto’s collaboration with Roche Diagnostics. ...
-
15. august 2025Meddelelse nr. 19 BioPortos delårsresultat for andet kvartal 2025 - Fortsat fremdrift med fuld eksekvering af strategiske mål og stærk NGAL-salgsvækst. København, Danmark, 15. august...
-
August 15, 2025Announcement no. 19 BioPorto Interim Result for the Second Quarter of 2025 - Continued progress with full execution of strategic objectives and strong NGAL sales growth. Copenhagen,...